Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceuticals	504.36M	517.83M	526.47M	578.32M	706.30M
Pharmaceuticals Growth	-2.60%	-1.64%	-8.97%	-18.12%	-23.61%
Total	504.36M	517.83M	526.47M	578.32M	706.30M
Total Growth	-2.60%	-1.64%	-8.97%	-18.12%	-23.61%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Northeast China Region	16.55M	19.98M	27.58M	56.56M	71.76M
Northeast China Region Growth	-17.21%	-27.53%	-51.24%	-21.19%	-14.48%
North China	108.46M	81.56M	73.47M	80.15M	91.68M
North China Growth	32.98%	11.02%	-8.33%	-12.58%	-29.07%
East China	189.06M	220.46M	238.87M	249.78M	333.86M
East China Growth	-14.24%	-7.71%	-4.37%	-25.18%	-19.52%
Southern China	48.76M	40.77M	30.93M	32.27M	47.26M
Southern China Growth	19.61%	31.79%	-4.14%	-31.72%	-17.60%
Central China Region	47.80M	46.91M	46.24M	53.96M	65.36M
Central China Region Growth	1.90%	1.46%	-14.31%	-17.45%	-36.13%
Northwestern Region	24.29M	24.59M	30.74M	31.63M	28.39M
Northwestern Region Growth	-1.22%	-20.03%	-2.80%	11.40%	-27.56%
Southwest Region	67.19M	81.71M	74.91M	66.46M	65.76M
Southwest Region Growth	-17.77%	9.07%	12.72%	1.06%	-32.14%
Unallocated	2.25M	1.85M	3.73M	7.52M	2.21M
Unallocated Growth	21.43%	-50.28%	-50.37%	240.42%	198.58%
Total	504.36M	517.83M	526.47M	578.32M	706.30M
Total Growth	-2.60%	-1.64%	-8.97%	-18.12%	-23.61%

Source: S&P Global Market Intelligence.